<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8336448</article-id>
    <article-id pub-id-type="pmid">34252948</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab279</article-id>
    <article-id pub-id-type="publisher-id">btab279</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Macromolecular Sequence, Structure, and Function</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MS2Planner: improved fragmentation spectra coverage in untargeted mass spectrometry by iterative optimized data acquisition</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zuo</surname>
          <given-names>Zeyuan</given-names>
        </name>
        <aff><institution>Computational Biology Department, Carnegie Mellon University</institution>, Pittsburgh, PA 15213, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cao</surname>
          <given-names>Liu</given-names>
        </name>
        <aff><institution>Computational Biology Department, Carnegie Mellon University</institution>, Pittsburgh, PA 15213, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Nothia</surname>
          <given-names>Louis-Félix</given-names>
        </name>
        <aff><institution>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego</institution>, La Jolla, CA 92093, <country country="US">USA</country></aff>
        <xref rid="btab279-cor1" ref-type="corresp"/>
        <!--louisfelix.nothias@gmail.com-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Mohimani</surname>
          <given-names>Hosein</given-names>
        </name>
        <aff><institution>Computational Biology Department, Carnegie Mellon University</institution>, Pittsburgh, PA 15213, <country country="US">USA</country></aff>
        <xref rid="btab279-cor1" ref-type="corresp"/>
        <!--hoseinm@andrew.cmu.edu-->
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab279-cor1">To whom correspondence should be addressed. <email>hoseinm@andrew.cmu.edu</email> or <email>louisfelix.nothias@gmail.com</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-07-12">
      <day>12</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <volume>37</volume>
    <issue>Suppl 1</issue>
    <issue-title>ISMB/ECCB 2021 Proceedings</issue-title>
    <fpage>i231</fpage>
    <lpage>i236</lpage>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab279.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Untargeted mass spectrometry experiments enable the profiling of metabolites in complex biological samples. The collected fragmentation spectra are the metabolite’s fingerprints that are used for molecule identification and discovery. Two main mass spectrometry strategies exist for the collection of fragmentation spectra: data-dependent acquisition (DDA) and data-independent acquisition (DIA). In the DIA strategy, all the metabolites ions in predefined mass-to-charge ratio ranges are co-isolated and co-fragmented, resulting in multiplexed fragmentation spectra that are challenging to annotate. In contrast, in the DDA strategy, fragmentation spectra are dynamically and specifically collected for the most abundant ions observed, causing redundancy and sub-optimal fragmentation spectra collection. Yet, DDA results in less multiplexed fragmentation spectra that can be readily annotated.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We introduce the MS2Planner workflow, an Iterative Optimized Data Acquisition strategy that optimizes the number of high-quality fragmentation spectra over multiple experimental acquisitions using topological sorting. Our results showed that MS2Planner increases the annotation rate by 38.6% and is 62.5% more sensitive and 9.4% more specific compared to DDA.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>MS2Planner code is available at <ext-link xlink:href="https://github.com/mohimanilab/MS2Planner" ext-link-type="uri">https://github.com/mohimanilab/MS2Planner</ext-link>. The generation of the inclusion list from MS2Planner was performed with python scripts available at <ext-link xlink:href="https://github.com/lfnothias/IODA_MS" ext-link-type="uri">https://github.com/lfnothias/IODA_MS</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Alfred P. Sloan Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/100000879</institution-id>
          </institution-wrap>
          <!-- oupReleaseDelayRemoved from OA Article (00|0) -->
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health New Innovator Award</institution>
          </institution-wrap>
          <!-- oupReleaseDelayRemoved from OA Article (00|0) -->
        </funding-source>
        <award-id>DP2GM137413</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>U.S. Department of Energy Award</institution>
          </institution-wrap>
          <!-- oupReleaseDelayRemoved from OA Article (00|0) -->
        </funding-source>
        <award-id>DE-SC0021340</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Untargeted tandem mass spectrometry is widely used for analysis of proteins and metabolites in complex biological samples (<xref rid="btab279-B16" ref-type="bibr">Koelmel <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btab279-B27" ref-type="bibr">Schrimpe-Rutledge <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btab279-B27" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btab279-B29" ref-type="bibr">Zha <italic toggle="yes">et al.</italic>, 2018</xref>). Data-dependent acquisition (DDA) is the most commonly used strategy to collect fragmentation mass spectra (MS2) (<xref rid="btab279-B12" ref-type="bibr">Hu <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btab279-B24" ref-type="bibr">Rudomin <italic toggle="yes">et al.</italic>, 2009</xref>). The fragmentation spectra are then identified by searching into spectral libraries or annotated with <italic toggle="yes">in silico</italic> tools (<xref rid="btab279-B7" ref-type="bibr">Cao <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btab279-B19" ref-type="bibr">Mohimani <italic toggle="yes">et al.</italic>, 2017</xref>, <xref rid="btab279-B20" ref-type="bibr">2018</xref>). In the standard DDA strategy, a survey full-scan mass spectrum (MS1) is periodically acquired to inform on the selection of top <italic toggle="yes">N</italic> most abundant precursor ions for subsequent MS2 acquisition, where <italic toggle="yes">N</italic> is often between 3 and 10 precursor ions per cycle (<xref rid="btab279-F1" ref-type="fig">Fig. 1a</xref>). While the sample complexity and the acquisition parameters influence the performance of DDA, many less abundant ions are left without any fragmentation spectra (<xref rid="btab279-B16" ref-type="bibr">Koelmel <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btab279-B24" ref-type="bibr">Rudomin <italic toggle="yes">et al.</italic>, 2009</xref>). Moreover, a portion of MS2 spectra collected in DDA have a low quality because they were collected at sub-optimal intensity levels. Repeating DDA on the same sample leads to the recollection of the most abundant ions and marginally improves the MS2 coverage (<xref rid="btab279-T1" ref-type="table">Table 1</xref>) (<xref rid="btab279-B11" ref-type="bibr">Hoopmann <italic toggle="yes">et al.</italic>, 2009</xref>; <xref rid="btab279-B18" ref-type="bibr">Kreimer <italic toggle="yes">et al.</italic>, 2016</xref>). One way to circumvent these disadvantages is by marking the precursor ions sampled in the previous run to exclude them from the next experiments in an iterative fashion (<xref rid="btab279-B10" ref-type="bibr">Hodge <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btab279-B17" ref-type="bibr">Koelmel <italic toggle="yes">et al.</italic>, 2017</xref>). Recently, dataset-dependent acquisition (DsDA) was introduced on quadrupole time-of-flight mass spectrometer to iteratively prioritize MS2 collection on the entire dataset in an automated fashion (<xref rid="btab279-B5" ref-type="bibr">Broeckling <italic toggle="yes">et al.</italic>, 2018</xref>). However, neither DDA nor DsDA optimizes the number of unique high-quality MS2 acquired for MS1 features.</p>
    <fig position="float" id="btab279-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>Comparison ofDDA and DIA strategy. (<bold>a</bold>) DDA strategy acquires a survey full-scan mass spectrum to select top <italic toggle="yes">N</italic> most abundant precursor ions for fragmentation spectra acquisition in the next several MS2 scans. (<bold>b</bold>) DIA fragments all the available precursors for MS2 scans in large predefined <italic toggle="yes">m/z</italic> and RT windows. The resulting MS2 are typically multiplexed and require further spectral deconvolution</p>
      </caption>
      <graphic xlink:href="btab279f1" position="float"/>
    </fig>
    <table-wrap position="float" id="btab279-T1">
      <label>Table 1.</label>
      <caption>
        <p>Comparison of different MS2 acquisition methods in untargeted tandem mass spectrometry experiments</p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1">Sensitivity</th>
            <th rowspan="1" colspan="1">Specificity</th>
            <th rowspan="1" colspan="1">Coverage</th>
            <th rowspan="1" colspan="1">Multiplexed spectra</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">DDA</td>
            <td rowspan="1" colspan="1">Medium</td>
            <td rowspan="1" colspan="1">Medium</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">Infrequent</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DIA</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">High</td>
            <td rowspan="1" colspan="1">Frequent</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">IODA with MS2Planner</td>
            <td rowspan="1" colspan="1">High</td>
            <td rowspan="1" colspan="1">High</td>
            <td rowspan="1" colspan="1">Medium</td>
            <td rowspan="1" colspan="1">Infrequent</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <p><bold><italic toggle="yes">Note</italic>:</bold> Sensitivity stands for the ratio of molecules present in the sample that can be identified by spectral library search. Specificity stands for the ratio of ions identified by spectral library search that correspond to a molecule in the sample. The coverage indicates proportion of ions with a fragmentation spectra collected. Note that high coverage is not equivalent to high sensitivity, since the spectra can be low quality/multiplexed, making it impossible to identify them by spectral library search. Note that due to the differential ionization response of each metabolites and instrument limit of detection, the sensitivity is fundamentally limited to a portion of molecules in these mass spectrometry experiments. Table is concluded from <xref rid="btab279-B27" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> (2019)</xref>, <xref rid="btab279-B6" ref-type="bibr">Broeckling <italic toggle="yes">et al.</italic> (2018)</xref>, <xref rid="btab279-B27" ref-type="bibr">Schrimpe-Rutledge <italic toggle="yes">et al.</italic> (2016)</xref>, <xref rid="btab279-B4" ref-type="bibr">Bilbao <italic toggle="yes">et al.</italic> (2015)</xref>, <xref rid="btab279-B12" ref-type="bibr">Hu <italic toggle="yes">et al.</italic> (2016)</xref>, <xref rid="btab279-B3" ref-type="bibr">Bauer <italic toggle="yes">et al.</italic> (2014)</xref>, <xref rid="btab279-B29" ref-type="bibr">Vidova and Spacil (2017)</xref>, <xref rid="btab279-B2" ref-type="bibr">Amodei <italic toggle="yes">et al.</italic> (2019)</xref>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Data-independent acquisition (DIA) systematically fragments all the available precursors for MS2 scans in large predefined <italic toggle="yes">m/z</italic> windows over time. Due to its large precursor ion isolation window, the resulting MS2 are typically multiplexed (several molecules captured in the same spectrum) (<xref rid="btab279-B4" ref-type="bibr">Bilbao <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btab279-B8" ref-type="bibr">Doerr, 2015</xref>). The post analysis of these fragmentation spectra requires advanced spectral deconvolution methods. In proteomics applications, large reference spectral libraries can be leveraged to improve the deconvolution process, which has facilitated the adoption of DIA (<xref rid="btab279-B9" ref-type="bibr">Gillet <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btab279-B27" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btab279-B29" ref-type="bibr">Zha <italic toggle="yes">et al.</italic>, 2018</xref>). However, the application of DIA to metabolomics is more challenging due to lower molecular weights of ions and narrower mass range that increases the multiplexing effect (<xref rid="btab279-B29" ref-type="bibr">Zha <italic toggle="yes">et al.</italic>, 2018</xref>). While efficient spectral deconvolution methods for metabolomics are also available (<xref rid="btab279-B28" ref-type="bibr">Tsugawa <italic toggle="yes">et al.</italic>, 2015</xref>), the deconvoluted fragmentation spectra are harder to identify by spectral library matching and by <italic toggle="yes">in silico</italic> annotation because they could be convoluted to some degree or inversely lacked actual fragment ions (<xref rid="btab279-B26" ref-type="bibr">Schmid <italic toggle="yes">et al.</italic>, 2020</xref>).</p>
    <p>To overcome these limitations, we introduce MS2Planner, an Iterative Optimized Data Acquisition (IODA) strategy for maximizing the coverage and quality of MS2 acquisition by untargeted mass spectrometry. While DDA acquisition collects MS2 spectra dynamically, MS2Planner requires a preliminary mass spectrometry experiment performed in MS1 full-scan mode. That preliminary data are used by MS2Planner to compute and schedule the optimal MS2 acquisition path across multiple subsequent iterative experiments. In proteomics, several strategies have been proposed to optimize MS2 coverage (<xref rid="btab279-B13" ref-type="bibr">Jaffe <italic toggle="yes">et al.</italic>, 2008</xref>; <xref rid="btab279-B25" ref-type="bibr">Rudomin <italic toggle="yes">et al.</italic>, 2009</xref>; <xref rid="btab279-B28" ref-type="bibr">Zerck <italic toggle="yes">et al.</italic>, 2013</xref>). MS2Planner is different from them in that it not only maximizes the number of ions with MS2 spectra acquired, but also maintains their quality. Our evaluation showed that MS2Planner outperforms DDA in sensitivity, specificity and quality of MS2 spectra collected. MS2Planner is currently available for Orbitrap-based instruments and could be adapted to other tandem mass spectrometers. <xref rid="btab279-T2" ref-type="table">Table 2</xref> describes the terminologies used in this article.</p>
    <table-wrap position="float" id="btab279-T2">
      <label>Table 2.</label>
      <caption>
        <p>Definitions of the terminologies</p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Term</th>
            <th align="left" rowspan="1" colspan="1">Definitions</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">MS1/MS1 scan</td>
            <td rowspan="1" colspan="1">Molecules are ionized and separated by retention time (RT) and mass-to-charge ratio (<italic toggle="yes">m/z</italic>). RT, <italic toggle="yes">m/z</italic> and intensity are obtained for each of the ions.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MS1 intensity</td>
            <td rowspan="1" colspan="1">The intensity of the ions. It is acquired during MS1 scan.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MS1 feature</td>
            <td rowspan="1" colspan="1">It refers to the whole MS1 profiles from a molecule.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MS1 apex</td>
            <td rowspan="1" colspan="1">MS1 scan data are processed by OpenMS workflow. It aligns MS1 features and removes ions found in the background control. It outputs an apex that consists of a tuple made by RT, <italic toggle="yes">m/z</italic>, and intensity of each MS1 feature.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MS1 run</td>
            <td rowspan="1" colspan="1">It refers to an entire run of MS1 scans over the RT range of the experiment.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">MS2/MS2 scan</td>
            <td rowspan="1" colspan="1">Designate fragmentation spectra that results from the fragmentation of molecules detected in MS1 scan and selected for tandem mass spectrometry experiment. It acquires RT, <italic toggle="yes">m/z</italic> and intensity for each ion of the fragments. These data can be used for molecule identification.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Total ion current</td>
            <td rowspan="1" colspan="1">It refers to the summation of intensities of ions in a scan or multiple scans.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">IODA</td>
            <td rowspan="1" colspan="1">Iterative Optimized Data Acquisition: an iterative acquisition strategy that relies on a preliminary analysis for optimizing the acquisition of MS2 scans over one or more iterative targeted-MS2 experiments.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Target ions/inclusion list</td>
            <td rowspan="1" colspan="1">It refers to a list of target ions to select for MS2 scan acquisition. When an inclusion list is added to the DDA method, the instrument triggers MS2 scan even if they are not amongst the topN most intense ions observed in the previous MS1 scan. When using the PRM scan, MS2 scans are collected for the target ions regardless of their detection in previous MS1 scans.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Dynamic exclusion</td>
            <td rowspan="1" colspan="1">Dynamic exclusion instructs the instrument to stop collecting additional MS2 scan for a period after the first MS2 collection. This avoids collecting duplicate fragment spectra based on <italic toggle="yes">mz</italic> of recently collected ion.</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Parallel reaction monitoring</td>
            <td rowspan="1" colspan="1">In this acquisition mode, MS2 scan(s) are collected for target ions regardless of their detection in MS1 scan.</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </sec>
  <sec>
    <title>2 Materials and Methods</title>
    <sec>
      <title>2.1 Problem formulation</title>
      <p>Based on a full preliminary MS1 run, our goal is to schedule an optimal data collection path to maximize the number of distinct MS2 acquisitions while avoiding sub-optimal intensity acquisitions. This problem can be formalized as follows:
<disp-formula id="E1"><label>(1)</label><mml:math id="M1" display="block" overflow="scroll"><mml:munder><mml:mtext>argmax</mml:mtext><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:munder><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>T</mml:mi></mml:munderover><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo> </mml:mo><mml:mi>s</mml:mi><mml:mo>.</mml:mo><mml:mi>t</mml:mi><mml:mo>.</mml:mo><mml:mo> </mml:mo></mml:math></disp-formula>
 <disp-formula id="E2"><label>(2)</label><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>T</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mtext>Int</mml:mtext></mml:mrow></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>*</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mtext>TIC</mml:mtext></mml:mrow></mml:math></disp-formula>
 <disp-formula id="E3"><label>(3)</label><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>|</mml:mo><mml:mo>≤</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></disp-formula>
 <disp-formula id="E4"><label>(4)</label><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>≤</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></disp-formula>
 <disp-formula id="E5"><label>(5)</label><mml:math id="M5" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:mo>{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>}</mml:mo><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mo> </mml:mo><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:math></disp-formula>where there are <italic toggle="yes">N</italic> metabolite features and T MS1 scans. <inline-formula id="IE1"><mml:math id="IM1" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mrow><mml:mtext>Int</mml:mtext></mml:mrow></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the MS1 intensity of metabolite feature <italic toggle="yes">i</italic> at retention <italic toggle="yes">t</italic>, while <inline-formula id="IE2"><mml:math id="IM2" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is a binary indicator of whether metabolite feature <italic toggle="yes">i</italic> is collected at retention time <italic toggle="yes">t</italic> by MS2. <italic toggle="yes">f</italic> is a function that predicts the total ion current (TIC) of MS2 based on the MS1 intensity. <inline-formula id="IE3"><mml:math id="IM3" display="inline" overflow="scroll"><mml:mn>1</mml:mn></mml:math></inline-formula> is an indicator function. TIC is a user defined threshold of MS2 TIC.</p>
      <p>The objective function (1) maximizes the number of distinct MS2 acquisitions. Constraint (2) means the expected MS2 TIC is greater than the user defined threshold TIC. Constraint (3) guarantees that each metabolite feature is only acquired once within a single interval of retention times. If a feature <italic toggle="yes">i</italic> is collected in two or more separate intervals, e.g. <inline-formula id="IE4"><mml:math id="IM4" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>, then <inline-formula id="IE5"><mml:math id="IM5" display="inline" overflow="scroll"><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>|</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula>, violating the constraint (3). Constraint (4) guarantees that at each retention time, there will be at most one acquisition. Zerck <italic toggle="yes">et al.</italic> also proposed a strategy based on preliminary full MS1 scans, but their optimization criteria does not maximizes the number high-quality features collected (<xref rid="btab279-B28" ref-type="bibr">Zerck <italic toggle="yes">et al.</italic>, 2013</xref>).</p>
      <sec>
        <title>Overview of MS2Planner</title>
        <p>MS2Planner recruits a dynamic programming approach to solve the optimization problem (1). The raw data of the preliminary MS1 run is a list of peaks in triplet format as <italic toggle="yes">m/z</italic>, RT and peak intensity, which are processed by OpenMS to detect MS1 apexes. After preprocessing, MS2Planner algorithm takes both the raw MS1 signals (defined as LC-MS features) and the apexes as input and computes the optimal MS2 acquisition paths in the <italic toggle="yes">m/z</italic>-RT. MS2Planner consists of the following steps: (i) raw MS1 signals are clustered based on their apexes, (ii) a directed acyclic graph (DAG) is constructed on MS1 features, referred to as feature-DAG, (iii) the MS2 acquisition path that maximizes the number of distinct features collected under the sub-optimal intensity constraints in the feature DAG is predicted, (iv) all the features on current path are excluded and the next optimal paths are predicted (<xref rid="btab279-F2" ref-type="fig">Fig. 2</xref>). Here, step (i) reduces the possibility of collecting chimeric spectra by targeting at apexes of peaks. The feature-DAG construction algorithm in step (ii) encodes the constraints <inline-formula id="IE6"><mml:math id="IM6" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>4</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, while the path finding algorithm in step (iii) guarantees that the paths will cover the maximum number of distinct features. The path scheduled by MS2Planner is the solution of optimization problem (1) (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Note</xref> 1).</p>
        <fig position="float" id="btab279-F2">
          <label>Fig. 2.</label>
          <caption>
            <p>MS2Planner pipeline. The method consists of (i) preprocessing and detecting raw MS1 features, (ii) constructing feature-DAG, (iii) scheduling the optimal path and (iv) excluding the features from this path and iteratively scheduling the next optimal paths</p>
          </caption>
          <graphic xlink:href="btab279f2" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>2.2 Mass spectrometry feature detection</title>
      <p>The preliminary mass spectrometry experiments (acquired in full MS1 scan mode) are processed using OpenMS to detect and align MS1 features (<xref rid="sup1" ref-type="supplementary-material">Supplementary Note</xref> 2) (<xref rid="btab279-B14" ref-type="bibr">Junker <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btab279-B22" ref-type="bibr">Pfeuffer <italic toggle="yes">et al.</italic>, 2017</xref>). MS1 signals are collected on both the biological sample of interest and the background/control sample, and MS1 features are detected using <italic toggle="yes">FeatureFinderMetabo</italic> and aligned across the samples using <italic toggle="yes">FeatureLinkerKD</italic>. Then, the apexes of MS1 features are detected and their intensities in the biological sample and in the background/control sample are reported. Features present in background/control samples are discarded.</p>
    </sec>
    <sec>
      <title>2.3 Constructing feature-DAG</title>
      <p>Feature-DAG is constructed based on raw MS1 features in four steps detailed below (<xref rid="btab279-F3" ref-type="fig">Fig. 3</xref>).</p>
      <fig position="float" id="btab279-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>Constructing feature-DAG. Feature-DAG is constructed based on raw MS1 signals in the following steps: (<bold>a</bold>) MS1 signals are clustered based on apexes. (<bold>b</bold>) For each cluster, all raw MS1 signals with the same retention times are regarded as a single node. (<bold>c</bold>) Edges with weight 1 (black) and weight 0 (green) are created depending on retention times and intensity of the nodes. (<bold>d</bold>) Each node is split into an in-node (<italic toggle="yes">u<sub>i</sub></italic>) and an out-node (<italic toggle="yes">u<sub>o</sub></italic>) to prevent recollecting the same feature</p>
        </caption>
        <graphic xlink:href="btab279f3" position="float"/>
      </fig>
      <sec>
        <title>2.3.1 Clustering MS1 signals</title>
        <p>MS2Planner utilizes raw MS1 signals and apexes from the OpenMS workflow. Raw signals are then mapped to clusters with apexes as centers, using nearest-neighbor model (<xref rid="btab279-F3" ref-type="fig">Fig. 3a</xref>) (<xref rid="btab279-B1" ref-type="bibr">Altman, 1992</xref>).</p>
      </sec>
      <sec>
        <title>2.3.2 Creating feature-DAG nodes</title>
        <p>Given clusters of MS1 features, MS2Planner bins raw MS1 signals in each cluster based on their retention times (<xref rid="btab279-F3" ref-type="fig">Fig. 3b</xref>). The intensity of the node is defined as the sum of intensity of the all raw MS1 signals inside it.</p>
      </sec>
      <sec>
        <title>2.3.3 Creating feature-DAG edges</title>
        <p>First, we connect each node to other nodes in the same cluster with a directed edge of weight 1 if: (i) the retention time of the second node is larger than that of the first node, and (ii) the total ion current (TIC) for the <inline-formula id="IE7"><mml:math id="IM7" display="inline" overflow="scroll"><mml:mi>m</mml:mi><mml:mo>/</mml:mo><mml:mi>z</mml:mi><mml:mo>-</mml:mo><mml:mtext>RT</mml:mtext></mml:math></inline-formula> window between the two nodes is higher than a user-defined threshold. MS2Planner trains a linear regression model to predict TIC for each <inline-formula id="IE8"><mml:math id="IM8" display="inline" overflow="scroll"><mml:mi>m</mml:mi><mml:mo>/</mml:mo><mml:mi>z</mml:mi><mml:mo>-</mml:mo><mml:mi>R</mml:mi><mml:mi>T</mml:mi></mml:math></inline-formula> window based on the integral of the intensity of features within the window (<xref rid="btab279-F4" ref-type="fig">Fig. 4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Note</xref> 3). In practice, this is equivalent to imposing a threshold on integrated MS1 signal or apex intensity directly. Here, as we assume that the majority of fragmentation spectra detected are not chimeric or multiplexed, TIC can be used as a proxy to estimate signal-to-noise level of a fragmentation mass spectrum (<xref rid="btab279-B21" ref-type="bibr">Moore <italic toggle="yes">et al.</italic>, 2000</xref>). Hence, constraint (2) is imposed to guarantee that the features collected are high quality.</p>
        <fig position="float" id="btab279-F4">
          <label>Fig. 4.</label>
          <caption>
            <p>Predicting TIC in <italic toggle="yes">m</italic>/<italic toggle="yes">z-</italic>RT intervals. Total ion current is linearly correlated to the integration of the intensity of all raw MS1 signals in the window. In order to make the prediction more robust against fluctuation in retention times, −Δ and + Δ is added to scan start time (<italic toggle="yes">t</italic><sub>s</sub>) and scan end time (<italic toggle="yes">t</italic><sub>e</sub>), respectively, where <inline-formula id="IE9"><mml:math id="IM9" display="inline" overflow="scroll"><mml:mrow><mml:mo>Δ</mml:mo><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula> s. Figure is reproduced from <xref rid="btab279-B23" ref-type="bibr">Pluskal <italic toggle="yes">et al.</italic> (2010)</xref></p>
          </caption>
          <graphic xlink:href="btab279f4" position="float"/>
        </fig>
        <p>Second, we connect each node to nodes from other clusters with a directed edge of weight 0 if the retention time of the second node is larger than the first node.</p>
        <p>Under different platform/acquisition parameters, the relationship between MS2 TIC and integral of raw MS1 signal could be very different. It is necessary for the user to first run a standard DDA-ex experiment to obtain the training data of a particular platform/acquisition parameters setting, and then learn a customized TIC prediction model with the training data. In this study, the threshold for the TIC of MS2 scan was empirically established based on the performance of the q-Orbitrap instrument used and the target level of sensitivity.</p>
      </sec>
      <sec>
        <title>2.3.4 Splitting the nodes</title>
        <p>One of the challenges with finding the maximum score path in feature-DAG is that it is possible for paths to explore and score some clusters multiple times (<xref rid="btab279-F5" ref-type="fig">Fig. 5</xref>). In order to avoid this phenomenon, we split each node to an in-node and an out-node. Inside each cluster, all the edges are directed from in-nodes to out-nodes. Between clusters, the edges are directed from out-nodes to in-nodes.</p>
        <fig position="float" id="btab279-F5">
          <label>Fig. 5.</label>
          <caption>
            <p>Splitting the nodes. The self-loop edge with weight 1 in node <italic toggle="yes">u<sup>t</sup></italic> results in duplicate scoring. In order to avoid this, we split each node into in-nodes and out-nodes. Each cluster is entered from an in-node, explored through an edge from an in-node to an out-node, and then exited from an out-node</p>
          </caption>
          <graphic xlink:href="btab279f5" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>2.4 Scheduling the optimal path</title>
      <p>MS2Planner schedules the optimal path in <inline-formula id="IE10"><mml:math id="IM10" display="inline" overflow="scroll"><mml:mrow><mml:mi>m</mml:mi><mml:mo>/</mml:mo><mml:mi>z</mml:mi><mml:mo>/</mml:mo><mml:mtext>RT</mml:mtext></mml:mrow></mml:math></inline-formula> plane that maximizes the number of unique features with TIC higher than a threshold (here we use threshold <inline-formula id="IE9000"><mml:math id="IM11" display="inline" overflow="scroll"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:math></inline-formula>). This is equivalent to finding the longest path that traverses maximum number of weight 1 edges in the feature-DAG. MS2Planner uses topological sorting to solve this problem efficiently (<xref rid="btab279-B15" ref-type="bibr">Kahn, 1962</xref>).</p>
    </sec>
    <sec>
      <title>2.5 Iteratively scheduling the next optimal paths</title>
      <p>Once a longest path is found, features in the path are excluded and MS2Planner is applied again to the rest of the features to find the next optimal path. This procedure is continued till reaching a user specified number of iterations.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Sample preparation</title>
      <p>The ‘NIH-NP’ sample consists of a mixture of ground truth molecules from the National Institute of Health natural product library. A biological background of fecal/tomato plant extracts was added to increase the complexity of the sample. The ‘Euphorbia’ plant extract was prepared by extracting the latex of <italic toggle="yes">Euphorbia peplus</italic> with acetonitrile. See the details of sample preparation and mass spectrometry experiments in <xref rid="sup1" ref-type="supplementary-material">Supplementary Note</xref> 5.</p>
    </sec>
    <sec>
      <title>3.2 Data collection</title>
      <p>The IODA experiments were initiated by analyzing the sample in MS1 full-scan mode. The MS1 data were then processed with the MS2Planner workflow to schedule the optimal path for MS2 acquisition. Subsequently, iterative acquisitions are performed to collect MS2 in targeted mode. Three different methods were used for MS2Planner: DDA with MS2Planner inclusion list (<italic toggle="yes">MS2Planner-DDA-inex</italic>), targeted-MS2 mode with MS2Planner inclusion list (<italic toggle="yes">MS2Planner-Targeted-inex</italic>) or targeted-MS2 mode with MS2Planner inclusion list without dynamic exclusion (<italic toggle="yes">MS2Planner-Targeted-in</italic>). Five replicates of standard DDA (DDA-ex) were collected as baseline comparison. <xref rid="btab279-T3" ref-type="table">Table 3</xref> details various features of these approaches.</p>
      <table-wrap position="float" id="btab279-T3">
        <label>Table 3.</label>
        <caption>
          <p>Comparison of acquisition methods used in the study</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Method</th>
              <th rowspan="1" colspan="1">MS2 acquisition mode</th>
              <th rowspan="1" colspan="1">DDA</th>
              <th rowspan="1" colspan="1">Inclusion list</th>
              <th rowspan="1" colspan="1">Dynamic exclusion</th>
              <th rowspan="1" colspan="1">Acquire MS2 from MS1</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">MS1 full scan</td>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">N/A</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DDA-ex</td>
              <td rowspan="1" colspan="1">DDA</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MS2Planner-DDA-inex</td>
              <td rowspan="1" colspan="1">DDA + targeted MS2</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MS2Planner-Targeted-inex</td>
              <td rowspan="1" colspan="1">Targeted MS2</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MS2Planner-Targeted-in</td>
              <td rowspan="1" colspan="1">Targeted MS2</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">No</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn2">
            <p><bold><italic toggle="yes">Note</italic>:</bold> In standard DDA (<italic toggle="yes">DDA-ex</italic>), acquisition is done in DDA mode (top five ions detected in MS1 scans), and MS2 dynamic exclusion is used to avoid collecting duplicate fragment spectra on recently collected ions. The <italic toggle="yes">MS2Planner-DDA-inex</italic> is a hybrid method that uses DDA for the ions detected in the previous MS1 survey scans, but prioritizes the acquisition of MS2 spectra for target ions which are predicted by <italic toggle="yes">MS2Planner</italic>. In the <italic toggle="yes">MS2Planner-Targeted-inex</italic> mode, the MS2 are collected only once for the targets in the inclusion list produced by MS2Planner. In the <italic toggle="yes">MS2Planner-Targeted-in</italic> method, the MS2 scans are collected for the targets regardless of their detection in the previous MS1 scans and no dynamic exclusion is used which can result in the acquisition of additional MS2 scans for target ion if extra duty cycle is available.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>3.3 Ms2planner detects more high quality unique compounds</title>
      <p>It is known that <italic toggle="yes">DDA-ex</italic> is biased toward collecting MS2 for the most intense ions. When running technical replicates in DDA, the instrument recollects MS2 for duplicate most intense ions. <xref rid="btab279-F6" ref-type="fig">Figure 6</xref> illustrate that 95.1% of the features in MS2Planner-Targeted-in mode appear in 1–2 MS2 spectra, while it is only 24.6% in <italic toggle="yes">DDA-ex</italic> mode. Therefore, as expected, <italic toggle="yes">MS2Planner-Targeted-in</italic> has a lower redundancy in fragment spectra acquisition.</p>
      <fig position="float" id="btab279-F6">
        <label>Fig. 6.</label>
        <caption>
          <p>Distribution of frequency of duplicate feature collection. In the MS2Planner IODA experiments, 98.8% and 95.1% of features are collected 1–2 times for <italic toggle="yes">MS2Planner-Targeted-inex</italic> and <italic toggle="yes">MS2Planner-Targeted-in</italic>, respectively, indicating a minimal redundancy in fragment spectra acquisition. In <italic toggle="yes">DDA-ex</italic> and <italic toggle="yes">MS2Planner-DDA-inex</italic>, this rates is approximately 25% indicating that 75% are redundantly collected more than 2 times as these strategies collect MS2 for the most intense features detected (once in each acquisition)</p>
        </caption>
        <graphic xlink:href="btab279f6" position="float"/>
      </fig>
      <p><italic toggle="yes">MS2Planner-Targeted-in</italic> also outperforms other methods in the cumulative number of detected unique ground truth molecules (<xref rid="btab279-F7" ref-type="fig">Fig. 7a</xref>). Only spectral annotations corresponding to ‘ground truth’ molecules that are known to be present in the NIH-NP sample are considered. These annotations are required to have: a cosine score <inline-formula id="IE11"><mml:math id="IM12" display="inline" overflow="scroll"><mml:mrow><mml:mo>≥</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></inline-formula>, shared peaks <inline-formula id="IE12"><mml:math id="IM13" display="inline" overflow="scroll"><mml:mrow><mml:mo>≥</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></inline-formula> and part-per million (ppm) error <inline-formula id="IE13"><mml:math id="IM14" display="inline" overflow="scroll"><mml:mrow><mml:mo>≤</mml:mo><mml:mn>20</mml:mn></mml:mrow></mml:math></inline-formula> compare to reference spectra. Over five experiments, with the same filter parameters, <italic toggle="yes">MS2Planner-Targeted-in, MS2Planner-Targeted-inex and MS2Planner-DDA-inex allowed to identify +38.6% (79) and +28.1% more ground truth molecules compared to DDA-ex (57), while MS2Planner-DDA-inex identified +8.7% more (57). Furthermore, we used the</italic> modified cosine score between the experimental MS2 spectra and the reference library spectra as a proxy to estimate the quality of experimental spectra collected. The cosine score represents the similarity of two MS2 spectra and ranges from 0 (not similar at all) to 1 (identical). <xref rid="btab279-F7" ref-type="fig">Figure 7</xref> shows that <italic toggle="yes">MS2Planner-Targeted-in</italic> produces also more high quality unique compounds than other three methods for all cosine thresholds.</p>
      <fig position="float" id="btab279-F7">
        <label>Fig. 7.</label>
        <caption>
          <p>Benchmarking on number of unique compounds and spectrum quality. (<bold>a</bold>) Number of unique compounds versus number of runs for different methods. <italic toggle="yes">MS2Planner-Targeted-in</italic> collects most unique compounds over five iterations among all methods. (<bold>b</bold>) Number of unique compounds identified at different cosine thresholds. <italic toggle="yes">MS2Planner-Targeted-in</italic> produce more high quality spectra than other methods</p>
        </caption>
        <graphic xlink:href="btab279f7" position="float"/>
      </fig>
      <sec>
        <title>MS2Planner improves sensitivity and specificity of data acquisition</title>
        <p>Sensitivity and specificity are computed from the ground truth compounds annotated from spectral library search. Sensitivity (true positive rate) is denoted as the number unique MS2 annotated as ground truth molecules over the number ground truth molecules in the sample. Specificity is defined as the number of unique MS2 ground truth molecules that were identified over the unique number of fragment spectra collected. <xref rid="btab279-F8" ref-type="fig">Figure 8</xref> shows that <italic toggle="yes">MS2Planner-Targeted-in</italic> and <italic toggle="yes">MS2Planner-Targeted-inex</italic> outperform <italic toggle="yes">DDA-ex</italic> and <italic toggle="yes">MS2Planner-DDA-inex</italic>. At cosine threshold of 0.5, the sensitivity of <italic toggle="yes">DDA-ex</italic>, <italic toggle="yes">MS2Planner-Targeted-in</italic>, <italic toggle="yes">MS2Planner-DDA-inex</italic> and <italic toggle="yes">MS2Planner-Targeted-inex</italic> is 11.2%, 18.2%, 12.7% and 15.9% respectively, while their specificity is 52.2%, 57.1%, 56.3% and 63.6%.</p>
        <fig position="float" id="btab279-F8">
          <label>Fig. 8.</label>
          <caption>
            <p>Sensitivity and specificity of different acquisition methods. Sensitivity and specificity for the NIH-NP dataset. These are computed from the annotation rate obtained by spectral library search against reference spectra. Here for cosine thresholds ranging from 0.1 to 0.6. <italic toggle="yes">MS2Planner-Targeted-in</italic> and <italic toggle="yes">MS2Planner-Targeted-inex</italic> outperform <italic toggle="yes">DDA-ex</italic> and <italic toggle="yes">MS2Planner-DDA-inex</italic></p>
          </caption>
          <graphic xlink:href="btab279f8" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>3.4 Performance on the <italic toggle="yes">Euphorbia</italic> plant sample</title>
      <p>To benchmark MS2Planner on a more complex plant extract, we performed a similar analysis on a <italic toggle="yes">Euphorbia</italic> extract. Mass spectral data were searched against all public spectral libraries and NIST. Over three replicates <italic toggle="yes">DDA-ex</italic> and three iterative acquisitions were performed for <italic toggle="yes">MS2Planner-Targeted-in</italic>, <italic toggle="yes">MS2Planner-DDA-inex</italic> collected 23.8%, 71.9%, 40.9% of features only 1–2 times. <italic toggle="yes">MS2Planner-Targeted-in</italic> has a lower redundancy in fragment spectra acquisition (<xref rid="btab279-F9" ref-type="fig">Fig. 9</xref>).</p>
      <fig position="float" id="btab279-F9">
        <label>Fig. 9.</label>
        <caption>
          <p>Distribution of frequency of duplicate feature collection on the <italic toggle="yes">Euphorbia</italic> plant data. DDA-ex, MS2Planner-DDA-inex and MS2Planner-Targeted-in collected 23.8%, 40.9%, 71.9%, of MS1 features 1–2 times</p>
        </caption>
        <graphic xlink:href="btab279f9" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>Standard DDA and its variants use a greedy strategy that always collect the most abundant ions for MS2 acquisition based on the previous MS1 scan. MS2Planner, on the contrary, first acquires a complete MS1 profile of a sample, and then schedules the path in the <inline-formula id="IE14"><mml:math id="IM15" display="inline" overflow="scroll"><mml:mrow><mml:mi>m</mml:mi><mml:mo>/</mml:mo><mml:mi>z</mml:mi><mml:mo>/</mml:mo><mml:mtext>RT</mml:mtext></mml:mrow></mml:math></inline-formula> plane to maximize the coverage and the quality of MS2 acquired. MS2Planner is an IODA strategy for untargeted mass spectrometry analysis who has ‘see the future’ and can plan ahead. Our evaluation showed that IODA with MS2Planner offers higher annotation rate than standard DDA, as well as higher sensitivity and specificity. While its iterative nature implies more experimental time, IODA with MS2Planner expands the analytical depth of untargeted mass spectrometry. In addition, and unlike DIA, the supplementary MS2 spectra collected can be readily employed for <italic toggle="yes">in silico</italic> annotation. We argue that the possibility of high coverage in qualitative MS2 coupled with the recent methodological advances in MS2 annotation is opening the ‘deep metabolomics’ era, where metabolites content can be detected and annotated at unprecedented depths. MS2Planner can be applied on other mass spectrometry platforms but is particularly adapted to q-Orbitrap instrument as it empowers the dynamic C-trap filling capability. Indeed, ion accumulation time is adjusted for each MS2 based on the input stream of ions available. Actually, the modulation of C-trap specific parameters (maximum filling time and maximum number of ions accumulated) has the potential to further increase the sensitivity of IODA with MS2Planner. From a practical standpoint, a typical use case for deep metabolomics acquisition would be analyzing all samples by high-throughput DDA or DIA and performing IODA on representative sample(s) for comprehensive MS2 acquisition and annotation.</p>
    <p>While MS2Planner improves on the sensitivity of the existing methods, currently the sensitivity of all the presented methods remain below 30%. Various experimental and computational improvements are needed to achieve higher sensitivity rates, including improvements in retention of small molecules in liquid chromatography, improvements in acquisition of low intensity features, and improvement in spectral library search. In practice, to reach sensitivity rates near 100%, one needs to conduct ionization in both positive and negative modes (as many small molecules do not fragment in positive mode), while using both liquid and gas chromatography with different chromatographic conditions.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btab279_Supplementary_Data</label>
      <media xlink:href="btab279_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We thank Mustafa Guler for his insightful comments on the manuscript. We thank Pieter C. Dorrestein (University of California San Diego) for supporting this study, Melissa Esposito (UCSD) for valuable comments on the manuscript and Mingxun Wang (UC San Diego) for assistance in running OpenMS tools in a Binder environment.</p>
    <sec>
      <title>Funding</title>
      <p>The work of Z.Z., L.C. and H.M. was supported by a research fellowship from the11 Alfred P. Sloan Foundation, a National Institutes of Health New Innovator Award [DP2GM137413] and a U.S. Department of Energy Award [DE-SC0021340].</p>
      <p><italic toggle="yes">Conflict of interest</italic>: H.M is co-founder and has equity interests from Chemia.ai, LLC. The other authors declare no competing interests.</p>
      <p><italic toggle="yes">Data availability</italic>: All the data supporting the findings of the paper are either available within the article and supplementary information or in public repository. GNPS job IDs are available in Supplementary Table S1 in Supplementary Notes 6. The mass spectrometry data and MS2Planner parameters were deposited into the MassIVE repository (ref: MSV000087109).</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab279-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Altman</surname><given-names>N.S.</given-names></string-name></person-group> (<year>1992</year>) <article-title>An introduction to kernel and nearest-neighbor nonparametric regression</article-title>. <source>Am. Statist</source>., <volume>46</volume>, <fpage>175</fpage>–<lpage>185</lpage>.</mixed-citation>
    </ref>
    <ref id="btab279-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amodei</surname><given-names>D.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Improving precursor selectivity in data-independent acquisition using overlapping windows</article-title>. <source>J. Am. Soc. Mass Spectrom</source>., <volume>30</volume>, <fpage>669</fpage>–<lpage>684</lpage>.<pub-id pub-id-type="pmid">30671891</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bauer</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>Evaluation of data-dependent and-independent mass spectrometric workflows for sensitive quantification of proteins and phosphorylation sites</article-title>. <source>J. Proteome Res</source>., <volume>13</volume>, <fpage>5973</fpage>–<lpage>5988</lpage>.<pub-id pub-id-type="pmid">25330945</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bilbao</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Processing strategies and software solutions for data-independent acquisition in mass spectrometry</article-title>. <source>Proteomics</source>, <volume>15</volume>, <fpage>964</fpage>–<lpage>980</lpage>.<pub-id pub-id-type="pmid">25430050</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Broeckling</surname><given-names>C.D.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Comprehensive tandem-mass-spectrometry coverage of complex samples enabled by data-set-dependent acquisition</article-title>. <source>Anal. Chem</source>., <volume>90</volume>, <fpage>8020</fpage>–<lpage>8027</lpage>.<pub-id pub-id-type="pmid">29846054</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname><given-names>L.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Metaminer: a scalable peptidogenomics approach for discovery of ribosomal peptide natural products with blind modifications from microbial communities</article-title>. <source>Cell Syst.s</source>, <volume>9</volume>, <fpage>600</fpage>–<lpage>608.e4</lpage>.</mixed-citation>
    </ref>
    <ref id="btab279-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doerr</surname><given-names>A.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Dia mass spectrometry</article-title>. <source>Nat. Methods</source>, <volume>12</volume>, <fpage>35</fpage>–<lpage>35</lpage>.</mixed-citation>
    </ref>
    <ref id="btab279-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gillet</surname><given-names>L.C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) <article-title>Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis</article-title>. <source>Mol. Cell. Proteomics</source>, <volume>11</volume>, O111.016717.</mixed-citation>
    </ref>
    <ref id="btab279-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hodge</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>Cleaning up the masses: exclusion lists to reduce contamination with HPLC-MS/MS</article-title>. <source>J. Proteomics</source>, <volume>88</volume>, <fpage>92</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">23501838</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoopmann</surname><given-names>M.R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2009</year>) <article-title>Post analysis data acquisition for the iterative MS/MS sampling of proteomics mixtures</article-title>. <source>J. Proteome Res</source>., <volume>8</volume>, <fpage>1870</fpage>–<lpage>1875</lpage>.<pub-id pub-id-type="pmid">19256536</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Technical advances in proteomics: new developments in data-independent acquisition</article-title>. <source>F1000Res</source>., <volume>5</volume>, <fpage>419</fpage>.</mixed-citation>
    </ref>
    <ref id="btab279-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jaffe</surname><given-names>J.D.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2008</year>) <article-title>Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification</article-title>. <source>Mol. Cell. Proteomics</source>, <volume>7</volume>, <fpage>1952</fpage>–<lpage>1962</lpage>.<pub-id pub-id-type="pmid">18534968</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Junker</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) <article-title>Toppas: a graphical workflow editor for the analysis of high-throughput proteomics data</article-title>. <source>J. Proteome Res</source>., <volume>11</volume>, <fpage>3914</fpage>–<lpage>3920</lpage>.<pub-id pub-id-type="pmid">22583024</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kahn</surname><given-names>A.B.</given-names></string-name></person-group> (<year>1962</year>) <article-title>Topological sorting of large networks</article-title>. <source>Commun. ACM</source>, <volume>5</volume>, <fpage>558</fpage>–<lpage>562</lpage>.</mixed-citation>
    </ref>
    <ref id="btab279-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koelmel</surname><given-names>J.P.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Expanding lipidome coverage using LC-MS/MS data-dependent acquisition with automated exclusion list generation</article-title>. <source>J. Am. Soc. Mass Spectrom</source>., <volume>28</volume>, <fpage>908</fpage>–<lpage>917</lpage>.<pub-id pub-id-type="pmid">28265968</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kreimer</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Advanced precursor ion selection algorithms for increased depth of bottom-up proteomic profiling</article-title>. <source>J. Proteome Res</source>., <volume>15</volume>, <fpage>3563</fpage>–<lpage>3573</lpage>.<pub-id pub-id-type="pmid">27569903</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohimani</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Dereplication of peptidic natural products through database search of mass spectra</article-title>. <source>Nat. Chem. Biol</source>., <volume>13</volume>, <fpage>30</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">27820803</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohimani</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Dereplication of microbial metabolites through database search of mass spectra</article-title>. <source>Nat. Commun</source>., <volume>9</volume>, <fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">29317637</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moore</surname><given-names>R.E.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2000</year>) <article-title>Method for screening peptide fragment ion mass spectra prior to database searching</article-title>. <source>J. Am. Soc. Mass Spectrom</source>., <volume>11</volume>, <fpage>422</fpage>–<lpage>426</lpage>.<pub-id pub-id-type="pmid">10790846</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pfeuffer</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Openms–a platform for reproducible analysis of mass spectrometry data</article-title>. <source>J. Biotechnol</source>., <volume>261</volume>, <fpage>142</fpage>–<lpage>148</lpage>.<pub-id pub-id-type="pmid">28559010</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pluskal</surname><given-names>T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2010</year>) <article-title>Mzmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data</article-title>. <source>BMC Bioinformatics</source>, <volume>11</volume>, <fpage>395</fpage>.<pub-id pub-id-type="pmid">20650010</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rudomin</surname><given-names>E.L.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2009</year>) <article-title>Directed sample interrogation utilizing an accurate mass exclusion-based data-dependent acquisition strategy (AMEX)</article-title>. <source>J. Proteome Res</source>., <volume>8</volume>, <fpage>3154</fpage>–<lpage>3160</lpage>.<pub-id pub-id-type="pmid">19344186</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B23">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Schmid</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>). Ion identity molecular networking in the GNPS environment. <italic toggle="yes">bioRxiv.</italic></mixed-citation>
    </ref>
    <ref id="btab279-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schrimpe-Rutledge</surname><given-names>A.C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Untargeted metabolomics strategies—challenges and emerging directions</article-title>. <source>J. Am. Soc. Mass Spectrom</source>., <volume>27</volume>, <fpage>1897</fpage>–<lpage>1905</lpage>.<pub-id pub-id-type="pmid">27624161</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsugawa</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>MS-dial: data-independent MS/MS deconvolution for comprehensive metabolome analysis</article-title>. <source>Nat. Methods</source>, <volume>12</volume>, <fpage>523</fpage>–<lpage>526</lpage>.<pub-id pub-id-type="pmid">25938372</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vidova</surname><given-names>V.</given-names></string-name>, <string-name><surname>Spacil</surname><given-names>Z.</given-names></string-name></person-group> (<year>2017</year>) <article-title>A review on mass spectrometry-based quantitative proteomics: targeted and data independent acquisition</article-title>. <source>Anal. Chim. Acta</source>, <volume>964</volume>, <fpage>7</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="pmid">28351641</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology</article-title>. <source>Anal. Bioanal. Chem</source>., <volume>411</volume>, <fpage>4349</fpage>–<lpage>4357</lpage>.<pub-id pub-id-type="pmid">30847570</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zerck</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>Optimal precursor ion selection for LC-MALDI MS/MS</article-title>. <source>BMC Bioinformatics</source>, <volume>14</volume>, <fpage>56</fpage>.<pub-id pub-id-type="pmid">23418672</pub-id></mixed-citation>
    </ref>
    <ref id="btab279-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zha</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Swathtomrm: development of high-coverage targeted metabolomics method using swath technology for biomarker discovery</article-title>. <source>Anal. Chem</source>., <volume>90</volume>, <fpage>4062</fpage>–<lpage>4070</lpage>.<pub-id pub-id-type="pmid">29485856</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
